"As a physician-researcher, I’ve been deep-diving into Leronlimab’s dual mechanism of action — not only as an anti-metastatic agent, but also as a potential immunotherapy primer."

Are there any current drugs with this "dual mechanism"; that is, it not only combats Tnbc, but identifies patients who may benefit from immunotherapy? Am I understanding this correctly?